Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16194809 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL3861770 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL18107219 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL11180766 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL18107180 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL20957509 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL12111175 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL20957475 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL20957484 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL4333408 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613646-A | Electrochromic material based on organic framework structure and electrochromic device thereof | 宁波祢若电子科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-102199093-A | Perylene disc-shaped liquid-crystal compound and preparation method thereof | UNIV BEIJING SCIENCE & TECH | 2011-09-28 | — | — | CN | claimed |
| US-4478952-A | Supported catalyst for olefin polymerization | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-10-23 | — | — | US | claimed |
| US-4371455-A | Supported catalyst for olefin polymerization | CONOCO, INC. (US) | 1983-02-01 | — | — | US | claimed |
| CN-119613646-A | Electrochromic material based on organic framework structure and electrochromic device thereof | 宁波祢若电子科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240210382-A1 | METHODS, DATABASE AND SYSTEM FOR USE WITH VIRAL INFECTION | RESPIRATION SCAN LTD. (IL) | 2024-06-27 | — | — | US | disclosed |
| CN-111954848-B | Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member | DIC株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-115433103-B | Synthesis method of isophorone nitrile | 山东新和成维生素有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-115433103-A | Synthesis method of isophorone nitrile | 山东新和成维生素有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-109153653-B | Novel compound, photocurable composition, cured product thereof, printing ink, and printed matter using the printing ink | DIC株式会社 | 2022-06-28 | — | — | CN | disclosed |
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | DIC CORPORATION (JP) | 2021-08-03 | — | — | US | disclosed |
| CN-111954848-A | Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member | DIC株式会社 | 2020-11-17 | — | — | CN | disclosed |
| EP-3306690-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | Merck Patent GmbH (DE) | 2018-04-11 | — | — | EP | disclosed |
| US-9738738-B2 | Polymers functionalized with activated nitrogen heterocycles containing a pendant functional group | BRIDGESTONE CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160289355-A1 | POLYMERS FUNCTIONALIZED WITH ACTIVATED NITROGEN HETEROCYCLES CONTAINING A PENDANT FUNCTIONAL GROUP | BRIDGESTONE CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| CN-105331447-A | Sterilizing cleaning composition with rich and stable foam | LI BIDAN | 2016-02-17 | — | — | CN | disclosed |
| CN-102199093-A | Perylene disc-shaped liquid-crystal compound and preparation method thereof | UNIV BEIJING SCIENCE & TECH | 2011-09-28 | — | — | CN | disclosed |
| US-20070021607-A1 | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them | ABBOTT GMBH & CO. KG. | 2007-01-25 | — | — | US | disclosed |
| US-5516767-A | PRODRUG AS HYPOGLYCEMIC AGENT | SANDOZ LTD. (CH) | 1996-05-14 | — | — | US | disclosed |
| US-5412137-A | Hypoglycemic agents | SANDOZ LTD. (CH) | 1995-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | EPB41, F12, CDK1 | LCK 2754/4885PPARD 4745/4885ZDHHC20 3610/4885 |
| US-20070021607-A1 | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them | OXTR, AVPR2, AVPR1A | LCK 4284/4885PPARD 1505/4885ZDHHC20 2307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.